Signaling pathways
-
BA3032 AQX-435Summary: AQX-435 is a potent activator. - BA3033 L6H21Summary: L6H21, a derivative, is an orally effective inhibitor of specific myeloid differentiation proteins.
- BA3034 DJ001Summary: DJ001 is a highly specific, selective and non-competitive protein tyrosine phosphatase-σ inhibitor.
- BA3035 CRT0066101Summary: CRT0066101 is a potent inhibitor with oral activity.
- BA3036 KS100Summary: KS100 is a potent inhibitor.
- BA3037 UZH1Summary: UZH1 is the racemate of UZH1a and UZH1b.
- BA3038 PyrazoloacridineSummary: Pyrazoloacridine (NSC366140) has anticancer activity and inhibits topoisomerase 1 and 2 activity (1and2).
- BA3039 TI17Summary: TI17 is an inhibitor of the thyroid hormone receptor-interacting protein Trip13 and has anticancer activity.
- BA3040 FerutininSummary: Ferutinin is a naturally occurring terpenoid, an estrogen receptor agonist and estrogen receptor agonist/antagonist.
- BA3041 Biotin-PEG6-ThalidomideSummary: Biotin-PEG6-Thalidomide is a linker, which belongs to the class PEG.